Refine
Is part of the Bibliography
- yes (7)
Document Type
- Journal article (7)
Language
- English (7)
Keywords
- B-cell lymphoma (1)
- Bowen’s disease, periungual (1)
- CD105 antigen (1)
- CD34 antigen (1)
- Human papillomavirus (1)
- Merkel cell carcinoma (1)
- Molecular imaging (1)
- Nail unit (1)
- Pathologic neovascularization (1)
- Positron emission tomography (1)
- Somatostatin receptor expression (1)
- bleomicina (1)
- bleomycin (1)
- brown band (1)
- dermatite flagelada (1)
- flagellate dermatitis (1)
- fungos shiitake (1)
- human (1)
- keratosis (1)
- lymphoma (1)
- macro-morphology (1)
- micro-morphology (1)
- microvessel density (1)
- shiitake dermatitis (1)
- shiitake mushrooms (1)
- shiitake-dermatite (1)
- skin neoplasms (1)
- subtypes (1)
- vascular endothelial growth (1)
Background
Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with increasing incidence, aggressive behavior and poor prognosis. Somatostatin receptors (SSTR) are expressed in MCC and represent a potential target for both imaging and treatment.
Methods
To non-invasively assess SSTR expression in MCC using PET and the radiotracers [68Ga]DOTA-D-Phe1-Tyr3-octreotide (DOTATOC) or -octreotate (DOTATATE) as surrogate for tumor burden. In 24 patients with histologically proven MCC SSTR-PET was performed and compared to results of computed tomography (CT).
Results
SSTR-PET detected primary and metastatic MCC lesions. On a patient-based analysis, sensitivity of SSTR-PET was 73% for nodal metastases, 100% for bone, and 67% for soft-tissue metastases, respectively. Notably, brain metastases were initially detected by SSTR-PET in 2 patients, whereas liver and lung metastases were diagnosed exclusively by CT. SSTR-PET showed concordance to CT results in 20 out of 24 patients. Four patients (17%) were up-staged due to SSTR-PET and patient management was changed in 3 patients (13%).
Conclusion
SSTR-PET showed high sensitivity for imaging bone, soft tissue and brain metastases, and particularly in combination with CT had a significant impact on clinical stage and patient management.